The core prevention targets and pathways include IL-6, AKT1, VEGFA targets, and AGE-RAGE, HIF-1, cAMP signaling pathways, etc. Moreover, SAA may be a preventive drug candidate of ischemic stroke screened by experiment. The gene discussed is AKT1; the disease is ischemic stroke.